We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




AI Tool Identifies and Distinguishes Between Difficult-to-Diagnose Cardiac Conditions on Echocardiograms

By HospiMedica International staff writers
Posted on 07 Apr 2023
Print article
Image: A new artificial intelligence tool can detect often overlooked heart diseases (Photo courtesy of Pexels)
Image: A new artificial intelligence tool can detect often overlooked heart diseases (Photo courtesy of Pexels)

Identifying hypertrophic cardiomyopathy and cardiac amyloidosis, two critical heart conditions can be quite challenging, even for seasoned cardiologists, resulting in patients waiting years to decades before receiving an accurate diagnosis. Without comprehensive testing, differentiating between these conditions and changes in heart shape and size that may be associated with normal aging can be perplexing for cardiologists. Notably, in the initial stages of the disease, both of these cardiac conditions can resemble the appearance of a heart that has aged and progressed naturally without any disease. Now, for the first time, an algorithm can spot these difficult-to-diagnose cardiac conditions.

Deposits of abnormal protein (amyloid) in heart tissue cause cardiac amyloidosis, also known as "stiff heart syndrome." These deposits replace healthy heart muscle, making it difficult for the heart to function correctly. Hypertrophic cardiomyopathy, on the other hand, causes the heart muscle to thicken and stiffen, leading to inadequate relaxation and blood filling, which can result in heart valve damage, fluid buildup in the lungs, and irregular heart rhythms. Physician-scientists at the Smidt Heart Institute at Cedars-Sinai (Los Angeles, CA, USA) have developed an artificial intelligence (AI) tool that can differentiate between these two life-threatening heart conditions effectively. The novel, two-step algorithm analyzed more than 34,000 cardiac ultrasound videos from Cedars-Sinai and Stanford Healthcare's echocardiography laboratories. The algorithm identified particular features related to heart wall thickness and chamber size and flagged patients who were suspicious of having these potentially unrecognized cardiac conditions.

The AI algorithm not only accurately distinguishes abnormal from normal cardiac conditions but can also identify which potentially life-threatening heart diseases may be present. It provides warning signals that can detect the disease well before it progresses to a stage that can impact health outcomes. With earlier diagnosis, patients can receive effective treatment sooner, prevent adverse clinical events, and improve their quality of life. The researchers hope that the technology will be utilized to identify patients at an early stage of the disease, as earlier diagnosis enables the most benefit from available therapies that can prevent the worst outcomes such as hospitalizations, heart failure, and sudden death.

“Our AI algorithm can pinpoint disease patterns that can’t be seen by the naked eye, and then use these patterns to predict the right diagnosis,” said David Ouyang, MD, a cardiologist in the Smidt Heart Institute and senior author of the study.

“One of the most important aspects of this AI technology is not only the ability to distinguish abnormal from normal, but also to distinguish between these abnormal conditions, because the treatment and management of each cardiac disease is very different,” added Susan Cheng, MD, MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at the Smidt Heart Institute and co-senior author of the study.

Related Links:
Cedars-Sinai 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgial Headlight
MedLED Chrome

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.